Obesity is associated with several detrimental health consequences, among them an increased risk for development of cancer, and an overall elevated mortality. Multiple factors like hyperinsulinemia, chronic microinflammation and oxidative stress may be involved. The comet assay has been proven to be very sensitive for detection of DNA damage and has been used to explore the relationship between overweight/obesity and DNA damage, but results are controversial. Very few investigations have been performed to correlate weight loss of obese individuals and possible reduction of DNA damage and these studies have not provided clear results. As currently, only surgical interventions (metabolic/bariatric surgery) enable substantial and sustained weight loss in the vast majority of morbidly obese patients, we analyzed whole blood samples of 56 subsequent patients prior, 6 and 12 months after bariatric surgery. No reduction of DNA damage was observed in comet assay analysis after 6 months despite efficient weight loss, but a significant reduction was observed 12 months after surgery. Concurrently, the ferric-reducing antioxidant power assay showed a significant reduction after 6 and 12 months. The level of oxidised glutathione and lipid peroxidation products were increased at 6 months but normalised at 12 months after surgery. As conclusion, a significant weight reduction in obese patients may help to diminish existing DNA damage besides improving many other health aspects in these patients.
Introduction
Obesity is associated with several detrimental health consequences especially increased risk for type 2 diabetes (T2DM), coronary heart disease, stroke, cancer and, as a consequence, increased mortality (1) . This is at least partly thought to be due to factors like hyperinsulinemia, chronic microinflammation as well as dysbalances in reactive oxygen species (ROS)-mediated signaling and antioxidative defense (2) . ROS are known to be mutagenic, causing DNA damage and expression of altered proteins, as well as tumor promoting by interference with signaling cascades (3) . The comet assay is a widely used test for the analysis of DNA damage which can be applied to many cell types and is used in genotoxicity testing of compounds as an in vitro pre-screening and an in vivo test (4) (5) (6) (7) , but also in human biomonitoring to assess potentially genotoxic exposures (8) (9) (10) . Significantly elevated comet tail length has also been shown in whole blood samples from patients with metabolic syndrome (11) . Therefore, the comet assay should be suitable to investigate the possible connection between obesity and DNA damage.
Not many studies which apply the comet assay for analysis of DNA damage in obesity as such are available, but several publications investigated diseases like diabetes type 2 (T2DM), polycystic ovary syndrome (PCOS) or metabolic syndrome, which are usually associated with elevated body mass index (BMI). Some of these studies have identified that increased BMI is an important contributor to DNA damage. A representative list of some important studies can be found in Table 1 .
Overall, it seems relatively clear that an elevated BMI is associated with higher DNA damage as measured in the comet assay, but data concerning weight loss and possible reduction of DNA damage are insufficient so far. This may be due to the fact that efficient weight loss is very difficult to achieve and maintain in human study groups and/or that a reduction of DNA damage only occurs after major weight loss or is only detectable in individuals with very high prior BMI. Surgical intervention has been shown to be the most effective option (19) and has not been studied for its effect on DNA damage. Therefore, in a prospective clinical study we analyzed whole blood samples of morbidly obese patients undergoing bariatric surgery with the comet assay as well as some oxidative stress parameters at 6 and 12 months after surgery.
Materials and methods

Materials
Unless stated otherwise, chemicals were purchased from Sigma Aldrich Germany (Munich, Germany). Cell culture media and reagents were purchased from PAA Laboratories (Pasching, Austria) and Life Technologies (Darmstadt, Germany). Fetal bovine serum (FBS) was from Biochrom (Berlin, Germany). Gel Red was purchased from Biotrend (Köln, Germany). Normal melting point agarose and superfrost slides were from Carl Roth (Karlsruhe, Germany).
Methods
Subjects
This study was carried out in order to determine the effect of weight loss induced by a bariatric surgery on oxidative stress and DNA damage parameters of morbidly obese subjects (n = 56 before, 6 and 12 months after the bariatric surgery). Blood sample collection was conducted in the Surgery and Endocrinology Departments, University Hospital of Wuerzburg. This study was approved by the Ethics Committee of the University of Wuerzburg.
Collection of whole blood and isolation of plasma
Blood samples were obtained from obese patients with BMI 51.10 ± 0.91 (47 female and 9 male) before and after (about 6 and 12 months) bariatric surgery. Whole blood was collected into commercially available EDTA tubes. Ten microlitres of whole blood was directly used to perform comet assay and rest of the blood was used for plasma and erythrocyte preparation. Plasma and erythrocyte were gained by density gradient centrifugation on histopaque. Blood samples were layered on histopaque surface (1:1). Blood, histopaque mixture was centrifugated at room temperature 1600 rpm for 30 min. After centrifugation, upper layer (plasma) was aspirated with the help of a pipette into epitubes and stored at −80°C until experiments were performed. Erythrocytes were washed with 5 ml of cold phosphate buffer at 1500 rpm for 15 min, 4°C and divided to aliquots to store at −80°C until the experiment.
Preparation of positive and negative controls
To control for day-to-day variations in the comet assay, each day positive and negative control samples were run together with the The alkaline comet assay with cryopreserved PBMCs (18) blood samples. MMS (100 µM for 4 h) treated HL60 cells were used as positive control and DMSO (1% DMSO for 4 h) treated HL60 cell as negative control. Positive and negative control samples were treated once and divided into many aliquots to be stored at −80°C. Each day one positive and one negative control were taken from −80°C and thawed at 4°C slowly. After thawing, they were mixed with 600 µl of 0.8% LMP agarose and 45 µl of these mixtures was placed on a fully frosted slide that was coated with 1.5% of normal melting point agarose. After this step, positive and negative controls were used in comet assay together with blood samples as described in below. The average values of the concurrent methodological positive controls (MMS-treated HL60 cells; 100 µM for 4 h; 35 samples) and negative controls (solvent control HL60 cells; 1% Dimethyl sulfoxide (DMSO) for 4 h; 35 samples) were 4.18 ± 0.33 (mean ± SEM) and 1.64 ± 0.17 (mean ± standard error of the mean (SEM)), respectively.
Alkaline comet assay
Ten microlitres of whole blood were mixed with 160 µl of 0.8% low melting point agarose at 37°C. Forty-five microlitres of blood-agarose mixture were placed on a fully frosted slide that was coated with 1.5% of normal melting point agarose. The cell suspension was covered with a cover glass and the slides were kept at 4°C for briefly to solidify the mixture. After gentle removal of the cover glass, slides were kept in a lysis solution (1% Triton X-100, 10% dimethyl sulfoxide and 89% lysis buffer containing 10 mM Tris, pH 10; 1% Na-sarcosine; 2.5 M NaCl; and 100 mM Na2EDTA) for 1 h in dark at 4°C. After the lysis step, to allow DNA unwinding, the slides were placed in an electrophoresis chamber that was filled with fresh electrophoresis buffer (300 mM NaOH and 1 mM Na2EDTA, pH 13) for 20 min on ice in dark. Then the electrophoresis was performed for 20 min at 25V and 300 mA on ice in dark. To neutralise the slides, they were immersed in 0. The plate was incubated at 37°C for 90 min and absorbance values were measured at 593 nm with plate reader spectra max 340.
Thiobarbituric acid reactive substances (TBARS) assay
Either 100 µl of plasma or standard (0, 0.0625, 0.125, 0.25, 0.5, 1, 2.5, and 10 µM MDA) were mixed with 100 µl of sodium dodecyl sulphate (SDS, 10%) and 4 ml of thiobarbituric acid (TBA) solution (2.7 mg TBA solved in 500 ml of acetic acid, sodium hydroxide mixture [acetic acid (3.5 M):sodium hydroxide (2 M), 1:1]. These mixtures were incubated for an hour in a vigorously boiling water bath. After boiling, standards and samples cooled down on ice and centrifugated at 4°C, 2800 rpm for 10 min. Clear supernatant was collected and utilised for absorbance measurement as duplicates at 532 nm with the help of spectra max 340-plate reader.
Enzymatic analysis of total and oxidised glutathione
A modified version of plate reader assay from Rahman et al. (20) , was utilised to determine the total and oxidised glutathione levels in erythrocytes of patients. The principle of this method was based on a reaction between sulfhydryl groups and Ellman's reagent (DTNB), which yields a colored product with a maximum absorbance at 412 nm. The rate of this reaction is known to be linear to the concentration of sulfhydryl groups or in our case to glutathione.
To be able to determine the total and oxidised glutathione levels, two different sample preparations were performed at the same time. For total glutathione analysis, 100 µl of erythrocytes were lysed by mixing with 400 µl of 5% cold metaphosphoric acid and centrifugated at 3000×g for 5 min at 4°C. For determination of oxidised glutathione (GSSG), the rest GSH was blocked by incubation 100 µl of erythrocytes with 10 µl of 1-methyl-2-vinylpyridinium (M2VP, 8.6 µg/µl) for 5 min on ice at dark. After the incubation step, the sample was mixed with 400 µl of cold 5% metaphosphoric acid and centrifugated at 3000×g for 5 min at 4°C. In each case (total or oxidised GSH), the supernatant was collected and used for the measurement. Twenty microlitres of standard (from 26.4, 13.2, 6.6, 3.3, 1.65 and 0.825 nmol/ml stocks) or sample (for total GSH diluted 1:30 and for GSSG 1:5) were pipetted into a 96-well plate as triplicate and 120 µl of DTNB/Glutathione reductase mixture [DTNB (2 mg/3 ml):Glutathione reductase (10 U/3 ml), 1:1) together with 60 µl of βNADPH (2 mg/3 ml) was added, respectively. The absorbance was measured at 412 nm from 0 to 5 min with 30 s intervals to monitor the reaction. Dilutions for samples, standards, enzymes and DTNB was done with a potassium phosphate buffer (pH 7.4). Quantified values were normalised with the hemoglobin content of the erythrocyte sample (see next section-Analysing hemoglobin content of erythrocyte samples).
Analysing hemoglobin content of erythrocyte samples
The rest of the erythrocyte samples from glutathione measurement was used for analysing the haemoglobin content with drabkin solution (400 mg sodium carbonate, 20 mg potassium cyanide and 8 mg potassium ferriccyanide in 500 ml water). Human haemoglobin (20 mg/ml water) was used to prepare the standard curve (final concentration of standards: 0, 0.2, 0.6, 1, 2, 3 and 4 mg/ml). All standard dilutions were done with drabkin solution. Ten µl of erythrocyte were mixed with 990 µl of drabkin solution and diluted further 1:2 with drabkin solution. After necessary dilutions were done, standards and samples were incubated for 20 min at room temperature in the dark. Finally, 200 µl of standard or sample were pipetted into a 96-well plate as triplicate and the absorbance was measured at 540 nm.
Quantification of blood composition
Blood smears were stained with May-Gruenwald staining solution and then immersed in Giemsa solution. Percentages of neutrophils, monocytes, lymphocytes, eosinophils and basophils were scored microscopically. This end-point was performed by the central laboratory of the University Hospital Wuerzburg.
Statistics
Statistical analysis was performed using SPSS 22 software. Data are presented as mean ± SEM. Normality of the data was checked with Shapiro-Wilk test and according to the results either paired sample t-test or the Wilcoxon test was performed to check for significant differences between individual groups. Results were considered significant with P ≤ 0.05.
Results
General characteristics of studied population
The study participants were at an average age of 44.70 ± 1.42 years (mean ± SEM) with a BMI of 51.10 ± 0.91 (mean ± SEM) before surgery. Six months after surgery, body weight and BMI were reduced significantly compared to before. Twelve months after surgery, body weight was further reduced compared to the 6-month time point ( Figure 1A and B). Weight loss in kg and weight reduction as percent of previous body weight are shown in Figure 2A and B, respectively.
Results of alkaline comet assay with whole blood samples
The alkaline comet assay was performed to determine the DNA damage in peripheral blood cells of obese patients. The reduction of DNA damage after weight loss can be seen in Figure 3 . There was no difference in DNA damage at 6 months after the surgery to before.
However, we observed a significant reduction of DNA damage at 12 months after the surgery compared to the 6-month time point and to before surgery.
Results of ferric-reducing antioxidant power assay with plasma samples
FRAP assay was performed with plasma samples in order to detect the reductive capacity of plasma samples in different time points. A small but significant reduction in iron-(II)-sulphate equivalents was measured at both time points after surgery ( Figure 4) .
Results of thiobarbituric reactive acid substances assay (TBARS) with plasma samples
Oxidative stress status of plasma samples was measured by analyzing the lipid peroxidation product malondialdehyde spectrometrically ( Figure 5 ). A slight increase was observed in malondialdehyde levels of plasma samples compared to before surgery at 6 months.
Results of enzymatic detection of total and oxidised glutathione with erythrocyte samples
Total and oxidised glutathione levels were significantly altered 6 months after the surgery. This alterations in total and oxidised glutathione levels showed a significant reduction in antioxidant status of these subjects after the surgery (6 and 12 months) ( Figure 6 ).
Results of scoring blood smear samples
The scored values were used to represent the percentage of neutrophils, monocytes, lymphocytes, eosinophils and basophils. Though all scored numbers were in the healthy reference range, a significant reduction was observed in the percentage of neutrophils and a significant increase in the percentage of lymphocyte after weight loss ( Table 2) .
Discussion
Clinically relevant and sustained weight loss is necessary to treat obesity-related diseases and prevent pre-mature mortality for severely obese patients. Current available conservative weight loss therapies are often not efficient to achieve sustained weight loss and reduce obesity related morbidity (21) . Therefore, bariatric surgery has become the therapeutic option of choice in these patients (13) . In this study, we used the comet assay to monitor the effect of bariatric surgery induced weight loss on spontaneous DNA damage in the blood cells of morbidly obese patients. We observed a small but significant decrease of DNA damage at 12 months after bariatric surgery. A literature search did not reveal another comparable study. Other available studies about DNA damage after weight loss are not comparable to our work. In one study, polycystic ovary syndrome (PCOS) affected women exhibited a decrease in DNA damage after a 12-week dietary weight reduction program (17), while another dietary intervention study (14) did not find any significant DNA damage reduction. A combined diet and exercise program (18) did not yield reduced DNA damage levels. However, weight loss was much smaller in these studies than in our investigation. A reduction of about 3% (14, 17) or of 9-11.4% of body weight (18) is less than half of the 22.68 ± 1.37 (mean ± SEM) of % weight reduction that we found after 6 months and the 29.20 ± 1.85 (mean ± SEM) % that resulted after 12 months. In addition, the starting weight in our study was much higher with a starting BMI of 51.10 ± 0.91 (mean ± SEM) compared to 29.8-30.73 in the various groups of the discussed publications. The fact that we observed a significant reduction only after 12 monthsdespite extensive weight loss already during the first 6 months-indicates that maintenance of the reduced body weight over a certain time period may be required for reduction of DNA damage. However, time kinetics and extend of alteration of DNA damage may also depend on the method of weight loss, with gastric bypass surgery being known to cause profound and complex metabolic changes. For example, altered uptake and process of intestinal glucose, alterations in gut microbiome and bile flow as well as manipulations in gut hormones have been described (22) (23) (24) (25) and may influence the reduction of DNA damage in the first months after surgery. Another important point to consider in comet assay human biomonitoring studies is the cellular composition of the blood. White blood cells are the relevant cell type for whole blood comet assay analysis, but subtypes have different DNA repair abilities as well as ROS production capacity (26) . Scoring indicated a significant change in percentages of neutrophils and lymphocytes after surgery in our study, although all values were within healthy reference ranges. This shift could be due to an improved microinflammation status in these patients. Although nothing is known about differences of white blood cell subtypes in DNA-damage levels in comet assay measurements, theoretically such a shift in cell types with different DNA repair capacity and ROS production ability might influence basal DNA levels.
A comparison of absolute DNA damage levels between our study and published findings regarding obesity or weight loss are impossible at this point, because of the heterogeneous experimental protocols used such as weight loss method and time-frame. For instance, some labs use frozen and others fresh samples, some use isolated peripheral blood mononuclear cells, some whole blood samples, in addition to the well-known interlaboratory variations in evaluation of comet assay slides (27) (28) (29) (30) .
A link between oxidative stress and obesity has been described frequently in the literature (31) (32) (33) . An overall reduction of oxidative stress after bariatric surgery induced weight loss has been reported with some ambiguous results within this general clear trend (34) (35) (36) . Here, antioxidative potential in the serum was even reduced and lipid peroxidation elevated after surgery, to a larger extend at 6 months than at 12 months after surgery. Total and oxidised glutathione levels were increased after surgery, which indicates increased oxidative stress. Although statistically significant for some data points, the effect size was small-especially in the case of antioxidant capacity-and may need to be confirmed in future studies. A possible explanation may be a lack of nutritional antioxidants after surgery due to reduced food uptake and compromised bioavailability/digestion. It also may be conceivable that an adaptation to the new digestive, hormonal and nutritional situation after surgery may be required or that the oxidative stress level improves only after weight loss has been completed and a new stable body weight has been achieved. The large weight reduction may produce more lipid peroxidation products and compromise peripheral blood antioxidant capacity during the process of weight loss. Furthermore, it has to be kept in mind that despite extensive weight loss the remaining BMI was still in the obesity range. For detection of oxidative DNA damage, the comet assay can be combined with the use of specific enzymes like FPG or OGG1, which recognise and remove oxidised purines. Application of these enzymes may yield additional information in a future study. Finally, it should be remembered that a correlation with cancer risk has not yet been established for the comet assay and therefore the biological relevance of such changes of DNA damage values in this assay [DNA in tail (%) from 3.54 ± 0.31 to 2.18 ± 0.17, mean ± SEM] is not yet known.
Since the number of human studies regarding DNA damage after weight loss is limited, rodent studies may need to be considered. For example, in a rat study, the obese group showed increased DNA damage in the comet assay, that was further increased by addition of triiodothyronine (T3), although this hormone led to a slight weight reduction (37) . However, T3 treatment did increase oxidative stress levels beyond that of the obese group. A caloric restriction group showed decreased oxidative stress and genomic damage in the comet assay, which were increased by T3 treatment. In our own study about weight loss after bariatric surgery or caloric restriction in a rat model, we detected elevated DNA damage (quantified by γH2Ax staining) in kidney, liver and colon tissue in the obese group and a reduction after either method of weight loss, combined with a reduction of urinary and tissue oxidative stress markers (38) . We did not find other rodent studies in which the link between DNA damage, obesity and weight loss was examined directly. Since it is known that caloric restriction below the normal intake with free food access can extend life span in several species, a considerable number of rodent studies about this relationship are available and seem to point towards a reduced genomic damage under caloric restriction, but that situation has been covered extensively elsewhere [reviewed in (39) ] and is entirely different from weight reduction based on obesity.
Overall, we have shown for the first time that extensive weight reduction reduced DNA damage in peripheral blood cells in addition to other published beneficial health effects. Further studies are needed to identify the most suitable weight loss method for efficient reduction of DNA damage, the minimal amount of reduction that is required and whether this effect can also be found with lower starting weights than the ones in this present study. The development of the oxidative stress level indicates additional stress during excessive weight loss, and future studies will have to cover a longer time period. Other endpoints for genomic damage levels may need to be added to future investigations to enable an estimation of the achievable modification of cancer risk. 1.81 ± 0.18 (n = 37) 1.74 ± 0.17 (n = 40) 1.80 ± 0.22 (n = 31) N.S. Basophils (%) 0.34 ± 0.03 (n = 36) 0.37 ± 0.03 (n = 40) 0.50 ± 0.06 (n = 31) N.S.
